4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Formycon AG (FYB) operates in the Biotechnology industry and is headquartered in Planegg, Germany with about 203 employees. Its market capitalization is roughly €329 million. In the fiscal year ended 2025-12-31, FYB reported €44M in revenue and (€65M) in net income.
Formycon AG, a biotechnology company, develops biosimilar drugs in Germany and Switzerland.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €44M | €70M | €78M | €42M | — |
| Gross Profit | €4M | €15M | €23M | €12M | — |
| Operating Income (EBIT) | (€30M) | (€24M) | (€0M) | (€18M) | — |
| Net Income | (€65M) | (€126M) | €76M | €36M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €740M | €772M | €890M | €854M | — |
| Total Liabilities | €340M | €310M | €388M | €497M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FYB viewer.
About TickerBase · Data methodology & sources · Privacy · Terms